Hoe verhoudt CAJ's PS Ratio zich tot zijn concurrenten?

CAJ is duur op basis van de Price-To-Sales -ratio ( 1.7 x) vergeleken met het gemiddelde van de peer ( 1 x).

Hoe verhoudt CAJ's PS Ratio zich tot andere bedrijven in de AU Healthcare industrie?

CAJ is duur op basis van de Price-To-Sales -ratio ( 1.7 x) vergeleken met het Australian Healthcare -industriegemiddelde ( 1.5 x).

Wat is CAJ's PS Ratio vergeleken met zijn Fair PS Ratio? Dit is de verwachte PS Ratio, rekening houdend met de verwachte winstgroei van het bedrijf, winstmarges en andere risicofactoren.

CAJ is duur op basis van de Price-To-Sales Ratio ( 1.7 x) vergeleken met de geschatte Fair Price-To-Sales Ratio ( 0.8 x).

Wat is de reële prijs van CAJ als we kijken naar de toekomstige kasstromen? Voor deze schatting gebruiken we een Discounted Cash Flow-model.

CAJ ( A$0.37 ) handelt boven onze schatting van [[eerlijke waarde]] ( A$0.33 )

Wat is de 12-maandsprognose van de analisten en hebben we enig statistisch vertrouwen in het consensuskoersdoel?

De koersdoelstelling is lager dan de huidige aandelenkoers.

Capitol Health (ASX:CAJ) - Aandelenkoers, Nieuws & Analyse

CAJ Overzicht aandelen

Capitol Health Limited levert modaliteiten voor diagnostische beeldvorming en aanverwante diensten aan de gezondheidszorgmarkt in Australië. Meer informatie

CAJ fundamentele analyse
Sneeuwvlok Score
Waardering	0/6
Toekomstige groei	4/6
Prestaties in het verleden	0/6
Financiële gezondheid	2/6
Dividenden	1/6

Beloningen

De winst zal naar verwachting met 68.36% per jaar groeien

Risicoanalyse

Heeft een hoog schuldenniveau

Capitol Health Limited Concurrenten

Integral Diagnostics

ASX:IDX

AU$678.4m

Australian Clinical Labs

ASX:ACL

AU$692.4m

Healthia

ASX:HLA

AU$252.1m

Healius

ASX:HLS

AU$954.9m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Capitol Health
Historische aandelenkoersen
Huidige aandelenkoers	AU$0.37
52 Week Hoogtepunt	AU$0.39
52 Week Laag	AU$0.20
Bèta	0.63
11 maand verandering	-5.13%
3 maanden verandering	21.31%
1 Jaar Verandering	80.49%
33 jaar verandering	5.71%
5 jaar verandering	57.45%
Verandering sinds IPO	39.62%

Recent nieuws en updates

Recent updates

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Mar 05

Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Feb 14

Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?

Jan 19

Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?

Dec 22

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Dec 01

Here's Why We Don't Think Capitol Health's (ASX:CAJ) Statutory Earnings Reflect Its Underlying Earnings Potential

Aug 17

Is Now An Opportune Moment To Examine Capitol Health Limited (ASX:CAJ)?

Jul 25

Is Capitol Health Limited's (ASX:CAJ) Latest Stock Performance A Reflection Of Its Financial Health?

Jul 04

Rendement voor aandeelhouders

	CAJ	AU Healthcare	AU Markt
7D	-2.6%	0.7%	1.5%
1Y	80.5%	4.0%	17.2%

Rendement versus industrie: CAJ overtrof de Australian Healthcare industrie, die het afgelopen jaar een rendement 4 % opleverde.

Rendement versus markt: CAJ overtrof de Australian markt, die het afgelopen jaar een rendement opleverde van 17.2 %.

Prijsvolatiliteit

Is CAJ's price volatile compared to industry and market?
CAJ volatility
CAJ Average Weekly Movement	4.3%
Healthcare Industry Average Movement	5.1%
Market Average Movement	8.6%
10% most volatile stocks in AU Market	17.3%
10% least volatile stocks in AU Market	3.4%

Stabiele aandelenkoers: CAJ heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 4% ) van CAJ is het afgelopen jaar stabiel geweest.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2005	1,000	Justin Walter	www.capitolhealth.com.au

Capitol Health Limited levert diagnostische beeldvormingsmodaliteiten en aanverwante diensten aan de gezondheidszorgmarkt in Australië. Het bedrijf biedt een reeks diagnostische beeldvormingsdiensten aan, waaronder algemene röntgenstralen, magnetische resonantiebeeldvorming, echografie, mammografie, Doppler, orthopantomografie, echocardiografie, computertomografie, CT-angiografie, CT met kegelstraal, nucleaire geneeskunde, botdensitometrie en fluoroscopie. Het beheert verschillende klinieken in Victoria, Tasmanië, West-Australië en Zuid-Australië onder de merknaam Capital Radiology, evenals onder de merknamen Imaging Olympic Park, Radiology Tasmania, Fowler Simmons Radiology, Womens' Imaging, Direct Radiology en Future Medical Imaging Group.

Capitol Health Limited Samenvatting

Hoe verhouden de winst en inkomsten van Capitol Health zich tot de beurswaarde?
CAJ fundamentele statistieken
Marktkapitalisatie	AU$394.45m
Inkomsten(TTM)	-AU$14.85m
Inkomsten(TTM)	AU$234.82m

1.7x

P/S-verhouding

-26.6x

Koers/Winstverhouding

Is CAJ overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
CAJ resultatenrekening (TTM)
Inkomsten	AU$234.82m
Kosten van inkomsten	AU$178.96m
Brutowinst	AU$55.86m
Overige uitgaven	AU$70.71m
Inkomsten	-AU$14.85m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-0.014
Brutomarge	23.79%
Nettowinstmarge	-6.33%
Schuld/Eigen Vermogen Verhouding	74.8%

Hoe presteerde CAJ op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

2.2%

Huidig dividendrendement

-64%

Uitbetalingsratio

CAJ Overzicht aandelen

Beloningen

Risicoanalyse

Capitol Health Limited Concurrenten

ASX:IDX

AU$678.4m

ASX:ACL

AU$692.4m

ASX:HLA

AU$252.1m

ASX:HLS

AU$954.9m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Insufficient new directors

Capitol Health Limited, Annual General Meeting, Feb 28, 2025

Final dividend of AU$0.004 announced

Price target increased by 7.1% to AU$0.31

Full year 2024 earnings released: AU$0.014 loss per share (vs AU$0.011 loss in FY 2023)

Capitol Health Limited Provides Earnings Guidance for the Year 2025

Recent updates

Insufficient new directors

Capitol Health Limited, Annual General Meeting, Feb 28, 2025

Final dividend of AU$0.004 announced

Price target increased by 7.1% to AU$0.31

Full year 2024 earnings released: AU$0.014 loss per share (vs AU$0.011 loss in FY 2023)

Capitol Health Limited Provides Earnings Guidance for the Year 2025

Capitol Health Limited to Report Fiscal Year 2024 Results on Aug 22, 2024

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

Calculating The Fair Value Of Capitol Health Limited (ASX:CAJ)

Now 21% undervalued after recent price drop

Now 21% undervalued

First half dividend of AU$0.005 announced

First half 2024 earnings released: EPS: AU$0.002 (vs AU$0.015 loss in 1H 2023)

New major risk - Financial position

Now 20% undervalued

Capitol Health Limited to Report First Half, 2024 Results on Feb 29, 2024

Capitol Health Limited Appoints Brendon Pentland as the Chief Financial Officer, Effective 1 April 2024

Capitol Health Limited's (ASX:CAJ) Popularity With Investors Is Clear

Capitol Health (ASX:CAJ) Takes On Some Risk With Its Use Of Debt

Now 21% undervalued

Now 21% undervalued after recent price drop

Capitol Health Limited Announces the Resignation of Craig Bremner as Chief Financial Officer

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Price target decreased by 9.8% to AU$0.28

Capitol Health Limited, Annual General Meeting, Nov 15, 2023

Full year 2023 earnings: EPS misses analyst expectations

Capitol Health Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

Price target decreased by 9.6% to AU$0.33

Capitol Health Limited to Report First Half, 2023 Results on Feb 23, 2023

Now 21% undervalued

Now 21% undervalued

Capitol Health Limited (ASX:CAJ) completed the acquisition of Future Medical Imaging Group Pty Ltd.

Is Capitol Health Limited (ASX:CAJ) Worth AU$0.3 Based On Its Intrinsic Value?

Capitol Health Limited Declares Franked Dividend for the Six Months Ended June 30, 2022, Payable on October 21, 2022

Price target increased to AU$0.43

Capitol Health Limited, Annual General Meeting, Nov 15, 2022

Full year 2022 earnings: EPS misses analyst expectations

Capitol Health Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 21 October, 2022

Consensus EPS estimates fall by 12%

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Capitol Health Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on April 1, 2022

Capitol Health Limited to Report First Half, 2022 Results on Feb 24, 2022

Full year 2021 earnings released: EPS AU$0.012 (vs AU$0.001 in FY 2020)

Capitol Health (ASX:CAJ) Seems To Use Debt Rather Sparingly

Should You Investigate Capitol Health Limited (ASX:CAJ) At AU$0.37?

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Analysts increase EPS estimates to AU$0.012

First half 2021 earnings released: EPS AU$0.006 (vs AU$0.004 in 1H 2020)

Price target raised to AU$0.36

New 90-day high: AU$0.34

Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Capitol Health Limited (ASX:CAJ) acquired Direct Radiology.

Capitol Health Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: AU$0.28

Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?

Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?